146 related articles for article (PubMed ID: 7224784)
1. [Ataxia-telangiectasia: treatment with transfer factor (author's transl)].
Garcia Urra D; Pino Corral E; Ceballos Hernansanz A; Varela de Seijas Slocker E; Campos Castello J
Arch Neurobiol (Madr); 1981; 44(1):3-10. PubMed ID: 7224784
[No Abstract] [Full Text] [Related]
2. Transfer factor therapy in ataxia--telangiectasia.
Berkel AI; Ersoy F; Epstein LB; Spitler LE
Clin Exp Immunol; 1977 Sep; 29(3):376-84. PubMed ID: 201409
[TBL] [Abstract][Full Text] [Related]
3. [Personal experiences of immunotherapy using the transfer factor].
D'Amelio R; Franchi F; Aiuti F
Minerva Med; 1976 May; 67(24):1613-6. PubMed ID: 934516
[TBL] [Abstract][Full Text] [Related]
4. [Transfer factor (its use in immunotherapy of neoplasms and other diseases)].
Zduńczyk A
Wiad Lek; 1980 Jun; 33(11):877-81. PubMed ID: 6999743
[No Abstract] [Full Text] [Related]
5. [Ataxia telangiectasia syndrome. Clinical and immunological study of a case].
Dufier JL; Scheinmann P; Renard G; Blanck MF; Vialatte J; Polliot L
Arch Ophtalmol (Paris); 1976 Mar; 36(3):209-14. PubMed ID: 137704
[No Abstract] [Full Text] [Related]
6. [Treatment of neuroblastoma with transfer factor (author's transl)].
Prats J; Padulles J; Español T; García Calderón P; Martínez-Mora J
An Esp Pediatr; 1976 Nov; 9(8):41-3. PubMed ID: 1015680
[No Abstract] [Full Text] [Related]
7. [The dynamics of neurologic symptoms in ataxia-telangiectasia patients following transplatation of neonatal thymus-sternum complex].
Lopukhin IuM; Morozov IuI; Kalinina LV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(5):641-6. PubMed ID: 4454888
[No Abstract] [Full Text] [Related]
8. [The treatment of isolated cellular immune defect with transfer factor (author's transl)].
Göring HD; Fiehring C; Schröder I
Dermatol Monatsschr; 1980 Feb; 166(2):81-7. PubMed ID: 6967428
[No Abstract] [Full Text] [Related]
9. [Lack of neutrophil activation in children affected with T-lymphocyte deficiencies who are chronic carriers of HBsAg (author's transl)].
De Martino M; Orienti MR; Pisanu C; Biadaioli R; Vierucci A
Haematologica; 1979 Aug; 64(4):433-41. PubMed ID: 121578
[No Abstract] [Full Text] [Related]
10. [Technics and applications of transfer factor (author's transl)].
Edelman L; Reviron J
Pathol Biol (Paris); 1979 Dec; 27(10):647-8. PubMed ID: 395495
[TBL] [Abstract][Full Text] [Related]
11. Impaired lymphocyte transformation in ataxia-telangiectasia in part due to a plasma inhibitory factor.
McFarlin DE; Oppenheim JJ
J Immunol; 1969 Dec; 103(6):1212-22. PubMed ID: 4188334
[No Abstract] [Full Text] [Related]
12. [Immunological aspects of ataxia-telangectasia].
Jean R; Bonnet H; Serre M; Dumas R; Rieu D; Clot J; Rey JM; Bousquet JL; Hermans J
Arch Fr Pediatr; 1972 Apr; 29(4):446. PubMed ID: 5072179
[No Abstract] [Full Text] [Related]
13. [Cell immunity responses in patients with widespread neoplasias following administration of transfer factor (author's transl)].
Simó-Camps E; Vich JM; García Calderón PA; Bofill D; Grau A; Anguiz A; Forcadell I
Med Clin (Barc); 1980 May; 74(10):403-7. PubMed ID: 6968012
[No Abstract] [Full Text] [Related]
14. Transfer factor and its clinical application.
Schulkind ML; Ayoub EM
Adv Pediatr; 1980; 27():89-115. PubMed ID: 7013447
[No Abstract] [Full Text] [Related]
15. [A new approach to immunotherapy: the transfer factor].
Di Padova F
Minerva Med; 1979 May; 70(25):1773-85. PubMed ID: 379697
[TBL] [Abstract][Full Text] [Related]
16. ["Transfer factor" in ophthalmology (author's transl)].
Rocha H
Klin Monbl Augenheilkd; 1977 Jul; 171(1):63-70. PubMed ID: 302878
[TBL] [Abstract][Full Text] [Related]
17. [Clinico-immunologic indices in patients with the Louis-Bar syndrome following transplantation of the thymus and sternum].
Lopukhin IuM; Morozov IuI; Kalinina LV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(10):1484-91. PubMed ID: 4590542
[No Abstract] [Full Text] [Related]
18. Ataxia-telangiectasia. A case and review of the literature.
Ramazanoglu YM
Schweiz Rundsch Med Prax; 1984 Jan; 73(5):133-8. PubMed ID: 6366960
[No Abstract] [Full Text] [Related]
19. Therapeutic considerations for use of immunomodulators in the treatment of ataxia-telangiectasia.
Stebbing N
Kroc Found Ser; 1985; 19():339-52. PubMed ID: 3934346
[TBL] [Abstract][Full Text] [Related]
20. [Ataxia telangiectasia. Study of a patient with multisystemic involvement].
Espinel Garuz E; Ramió Masgrau R; de Gracia Roldán J; Vidal Plá R; Español Boren T
Rev Clin Esp; 1983 Oct; 171(1):61-5. PubMed ID: 6658086
[No Abstract] [Full Text] [Related]
[Next] [New Search]
